Global Epinephrine Market

Epinephrine Comprehensive Study by Type (Epinephrine Auto-injector, Epinephrine Prefilled Syringe, Ampoules and Vials, Combination Epinephrine Products), Application (Anaphylaxis, Cardiac Arrest, Others), Route of Administration (Intravenous, Oral, Subcutaneous, Intramuscular), Ingredients (Epinephrine Acetate, Epinephrine Bitartrate, Epinephrine Hydrochloride) Players and Region - Global Market Outlook to 2030

Epinephrine Market by XX Submarkets | Forecast Years 2024-2030 | CAGR: 11%  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
About Epinephrine
According to the Asthma and Allergy Foundation of America, 2014, anaphylaxis is a severe life-threatening allergic reaction occurring at least 1 in every 50 people in the United States. Epinephrine also is known as adrenaline is a hormone and neurotransmitter produced by the adrenal glands. This hormone is used to alter the effect of anaphylaxis (life-threatening allergic reaction) and is used as the first line of treatment. Most of the patients suffering from anaphylaxis use Epinephrine Auto-Injectors and can be administered by a nonmedical person also. The Epinephrine injections are commonly used against life-threatening allergic reactions caused by medications, insect bites and stings.

AttributesDetails
Study Period2018-2030
Base Year2023
UnitValue (USD Million)
CAGR11.0%


The market is fragmented by The manufacturers are focused on developing and commercializing innovative drugs and novel drug delivery systems of therapeutic molecules to improve patient quality of life and to cater the clinical shortcomings of the commercially available products. The players are also focused on the development new products such as Chlorofluorocarbon (CFC) free epinephrine auto-injectors. Analyst at AMA Research estimates that Global Players will contribute the maximum growth to Global Epinephrine market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

Mylan N.V.(United States), Pfizer, Inc. (United States), Teva Pharmaceuticals Industries Ltd. (Israel), Impax Laboratories, Inc. (United States), Kaleo, Inc. (United States), Adamis Pharmaceuticals Corporation (United States), Amphastar Pharmaceuticals (United States), Merit Pharmaceutical (United States), Tianjin Jinyao Group (China) and Bausch Health Companies (Canada) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research coverage are ALK- Abello A/S (Denmark), Sandoz (Germany) and INSYS Therapeutics,Inc. (United States).

Segmentation Overview
AMA Research has segmented the market of Global Epinephrine market by Type (Epinephrine Auto-injector, Epinephrine Prefilled Syringe, Ampoules and Vials and Combination Epinephrine Products), Application (Anaphylaxis, Cardiac Arrest and Others) and Region. On the basis of Type, Auto-Injector are dominating the market in the year 2023

On the basis of application, Anaphylaxis segment is dominating the market in the year 2023

On the basis of geography, the market of Epinephrine has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). North America region held largest market share in the year 2023. If we see Market by Route of Administration, the sub-segment i.e. Intravenous will boost the Epinephrine market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Ingredients, the sub-segment i.e. Epinephrine Acetate will boost the Epinephrine market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Influencing Trend:
The Launch of New Products Like Epipen By Companies

Market Growth Drivers:
Rising Incidence of Anaphylaxis Associated With Food Allergy, The Increasing Number of Patients Susceptible To Allergic Reactions and Increasing Demand for Automatic Injection Devices Leading to the Growth of Epinephrine Auto-Injectors Market

Challenges:
Side Effects Caused By Epinephrine Medications

Restraints:
Unavailability of Approved Drugs Due To the Increasing Number of Product Recalls by Various Developers

Opportunities:
Programs for Patient’s Assistance Carried out for an Uninsured Person and Continuous Product Modification Resulting in Demand for Automatic Injection Devices

Market Leaders and their expansionary development strategies
In September 2023, The Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) to ARS Pharmaceuticals regarding the New Drug Application (NDA) for neffy (intranasal epinephrine) for the treatment of severe allergic reactions (Type 1), including anaphylaxis, for adults and children weighing at least 30kg.
In March 2024, American Regent announces the launch of sulfite-free Epinephrine Injection, USP. Epinephrine Injection, USP, is indicated for emergency treatment of allergic reactions (Type I), including anaphylaxis, which may result from insect stings or bites, foods, drugs, sera, diagnostic testing substances and other allergens, as well as idiopathic anaphylaxis or exercise-induced anaphylaxis. Epinephrine is also indicated to increase mean arterial blood pressure in adult patients with hypotension associated with septic shock.


Key Target Audience
Physicians, Pharmaceutical companies, Government and Regulatory Bodies, Traders, Distributors, and Suppliers and Others

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.

Report Objectives / Segmentation Covered

By Type
  • Epinephrine Auto-injector
  • Epinephrine Prefilled Syringe
  • Ampoules and Vials
  • Combination Epinephrine Products
By Application
  • Anaphylaxis
  • Cardiac Arrest
  • Others
By Route of Administration
  • Intravenous
  • Oral
  • Subcutaneous
  • Intramuscular

By Ingredients
  • Epinephrine Acetate
  • Epinephrine Bitartrate
  • Epinephrine Hydrochloride

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Rising Incidence of Anaphylaxis Associated With Food Allergy
      • 3.2.2. The Increasing Number of Patients Susceptible To Allergic Reactions
      • 3.2.3. Increasing Demand for Automatic Injection Devices Leading to the Growth of Epinephrine Auto-Injectors Market
    • 3.3. Market Challenges
      • 3.3.1. Side Effects Caused By Epinephrine Medications
    • 3.4. Market Trends
      • 3.4.1. The Launch of New Products Like Epipen By Companies
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Epinephrine, by Type, Application, Route of Administration, Ingredients and Region (value and price ) (2018-2023)
    • 5.1. Introduction
    • 5.2. Global Epinephrine (Value)
      • 5.2.1. Global Epinephrine by: Type (Value)
        • 5.2.1.1. Epinephrine Auto-injector
        • 5.2.1.2. Epinephrine Prefilled Syringe
        • 5.2.1.3. Ampoules and Vials
        • 5.2.1.4. Combination Epinephrine Products
      • 5.2.2. Global Epinephrine by: Application (Value)
        • 5.2.2.1. Anaphylaxis
        • 5.2.2.2. Cardiac Arrest
        • 5.2.2.3. Others
      • 5.2.3. Global Epinephrine by: Route of Administration (Value)
        • 5.2.3.1. Intravenous
        • 5.2.3.2. Oral
        • 5.2.3.3. Subcutaneous
        • 5.2.3.4. Intramuscular
      • 5.2.4. Global Epinephrine by: Ingredients (Value)
        • 5.2.4.1. Epinephrine Acetate
        • 5.2.4.2. Epinephrine Bitartrate
        • 5.2.4.3. Epinephrine Hydrochloride
      • 5.2.5. Global Epinephrine Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
    • 5.3. Global Epinephrine (Price)
      • 5.3.1. Global Epinephrine by: Type (Price)
  • 6. Epinephrine: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2023)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Mylan N.V.(United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Pfizer, Inc. (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Teva Pharmaceuticals Industries Ltd. (Israel)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Impax Laboratories, Inc. (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Kaleo, Inc. (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Adamis Pharmaceuticals Corporation (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Amphastar Pharmaceuticals (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Merit Pharmaceutical (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Tianjin Jinyao Group (China)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Bausch Health Companies (Canada)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Epinephrine Sale, by Type, Application, Route of Administration, Ingredients and Region (value and price ) (2025-2030)
    • 7.1. Introduction
    • 7.2. Global Epinephrine (Value)
      • 7.2.1. Global Epinephrine by: Type (Value)
        • 7.2.1.1. Epinephrine Auto-injector
        • 7.2.1.2. Epinephrine Prefilled Syringe
        • 7.2.1.3. Ampoules and Vials
        • 7.2.1.4. Combination Epinephrine Products
      • 7.2.2. Global Epinephrine by: Application (Value)
        • 7.2.2.1. Anaphylaxis
        • 7.2.2.2. Cardiac Arrest
        • 7.2.2.3. Others
      • 7.2.3. Global Epinephrine by: Route of Administration (Value)
        • 7.2.3.1. Intravenous
        • 7.2.3.2. Oral
        • 7.2.3.3. Subcutaneous
        • 7.2.3.4. Intramuscular
      • 7.2.4. Global Epinephrine by: Ingredients (Value)
        • 7.2.4.1. Epinephrine Acetate
        • 7.2.4.2. Epinephrine Bitartrate
        • 7.2.4.3. Epinephrine Hydrochloride
      • 7.2.5. Global Epinephrine Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
    • 7.3. Global Epinephrine (Price)
      • 7.3.1. Global Epinephrine by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Epinephrine: by Type(USD Million)
  • Table 2. Epinephrine Epinephrine Auto-injector , by Region USD Million (2018-2023)
  • Table 3. Epinephrine Epinephrine Prefilled Syringe , by Region USD Million (2018-2023)
  • Table 4. Epinephrine Ampoules and Vials , by Region USD Million (2018-2023)
  • Table 5. Epinephrine Combination Epinephrine Products , by Region USD Million (2018-2023)
  • Table 6. Epinephrine: by Application(USD Million)
  • Table 7. Epinephrine Anaphylaxis , by Region USD Million (2018-2023)
  • Table 8. Epinephrine Cardiac Arrest , by Region USD Million (2018-2023)
  • Table 9. Epinephrine Others , by Region USD Million (2018-2023)
  • Table 10. Epinephrine: by Route of Administration(USD Million)
  • Table 11. Epinephrine Intravenous , by Region USD Million (2018-2023)
  • Table 12. Epinephrine Oral , by Region USD Million (2018-2023)
  • Table 13. Epinephrine Subcutaneous , by Region USD Million (2018-2023)
  • Table 14. Epinephrine Intramuscular , by Region USD Million (2018-2023)
  • Table 15. Epinephrine: by Ingredients(USD Million)
  • Table 16. Epinephrine Epinephrine Acetate , by Region USD Million (2018-2023)
  • Table 17. Epinephrine Epinephrine Bitartrate , by Region USD Million (2018-2023)
  • Table 18. Epinephrine Epinephrine Hydrochloride , by Region USD Million (2018-2023)
  • Table 19. South America Epinephrine, by Country USD Million (2018-2023)
  • Table 20. South America Epinephrine, by Type USD Million (2018-2023)
  • Table 21. South America Epinephrine, by Application USD Million (2018-2023)
  • Table 22. South America Epinephrine, by Route of Administration USD Million (2018-2023)
  • Table 23. South America Epinephrine, by Ingredients USD Million (2018-2023)
  • Table 24. Brazil Epinephrine, by Type USD Million (2018-2023)
  • Table 25. Brazil Epinephrine, by Application USD Million (2018-2023)
  • Table 26. Brazil Epinephrine, by Route of Administration USD Million (2018-2023)
  • Table 27. Brazil Epinephrine, by Ingredients USD Million (2018-2023)
  • Table 28. Argentina Epinephrine, by Type USD Million (2018-2023)
  • Table 29. Argentina Epinephrine, by Application USD Million (2018-2023)
  • Table 30. Argentina Epinephrine, by Route of Administration USD Million (2018-2023)
  • Table 31. Argentina Epinephrine, by Ingredients USD Million (2018-2023)
  • Table 32. Rest of South America Epinephrine, by Type USD Million (2018-2023)
  • Table 33. Rest of South America Epinephrine, by Application USD Million (2018-2023)
  • Table 34. Rest of South America Epinephrine, by Route of Administration USD Million (2018-2023)
  • Table 35. Rest of South America Epinephrine, by Ingredients USD Million (2018-2023)
  • Table 36. Asia Pacific Epinephrine, by Country USD Million (2018-2023)
  • Table 37. Asia Pacific Epinephrine, by Type USD Million (2018-2023)
  • Table 38. Asia Pacific Epinephrine, by Application USD Million (2018-2023)
  • Table 39. Asia Pacific Epinephrine, by Route of Administration USD Million (2018-2023)
  • Table 40. Asia Pacific Epinephrine, by Ingredients USD Million (2018-2023)
  • Table 41. China Epinephrine, by Type USD Million (2018-2023)
  • Table 42. China Epinephrine, by Application USD Million (2018-2023)
  • Table 43. China Epinephrine, by Route of Administration USD Million (2018-2023)
  • Table 44. China Epinephrine, by Ingredients USD Million (2018-2023)
  • Table 45. Japan Epinephrine, by Type USD Million (2018-2023)
  • Table 46. Japan Epinephrine, by Application USD Million (2018-2023)
  • Table 47. Japan Epinephrine, by Route of Administration USD Million (2018-2023)
  • Table 48. Japan Epinephrine, by Ingredients USD Million (2018-2023)
  • Table 49. India Epinephrine, by Type USD Million (2018-2023)
  • Table 50. India Epinephrine, by Application USD Million (2018-2023)
  • Table 51. India Epinephrine, by Route of Administration USD Million (2018-2023)
  • Table 52. India Epinephrine, by Ingredients USD Million (2018-2023)
  • Table 53. South Korea Epinephrine, by Type USD Million (2018-2023)
  • Table 54. South Korea Epinephrine, by Application USD Million (2018-2023)
  • Table 55. South Korea Epinephrine, by Route of Administration USD Million (2018-2023)
  • Table 56. South Korea Epinephrine, by Ingredients USD Million (2018-2023)
  • Table 57. Taiwan Epinephrine, by Type USD Million (2018-2023)
  • Table 58. Taiwan Epinephrine, by Application USD Million (2018-2023)
  • Table 59. Taiwan Epinephrine, by Route of Administration USD Million (2018-2023)
  • Table 60. Taiwan Epinephrine, by Ingredients USD Million (2018-2023)
  • Table 61. Australia Epinephrine, by Type USD Million (2018-2023)
  • Table 62. Australia Epinephrine, by Application USD Million (2018-2023)
  • Table 63. Australia Epinephrine, by Route of Administration USD Million (2018-2023)
  • Table 64. Australia Epinephrine, by Ingredients USD Million (2018-2023)
  • Table 65. Rest of Asia-Pacific Epinephrine, by Type USD Million (2018-2023)
  • Table 66. Rest of Asia-Pacific Epinephrine, by Application USD Million (2018-2023)
  • Table 67. Rest of Asia-Pacific Epinephrine, by Route of Administration USD Million (2018-2023)
  • Table 68. Rest of Asia-Pacific Epinephrine, by Ingredients USD Million (2018-2023)
  • Table 69. Europe Epinephrine, by Country USD Million (2018-2023)
  • Table 70. Europe Epinephrine, by Type USD Million (2018-2023)
  • Table 71. Europe Epinephrine, by Application USD Million (2018-2023)
  • Table 72. Europe Epinephrine, by Route of Administration USD Million (2018-2023)
  • Table 73. Europe Epinephrine, by Ingredients USD Million (2018-2023)
  • Table 74. Germany Epinephrine, by Type USD Million (2018-2023)
  • Table 75. Germany Epinephrine, by Application USD Million (2018-2023)
  • Table 76. Germany Epinephrine, by Route of Administration USD Million (2018-2023)
  • Table 77. Germany Epinephrine, by Ingredients USD Million (2018-2023)
  • Table 78. France Epinephrine, by Type USD Million (2018-2023)
  • Table 79. France Epinephrine, by Application USD Million (2018-2023)
  • Table 80. France Epinephrine, by Route of Administration USD Million (2018-2023)
  • Table 81. France Epinephrine, by Ingredients USD Million (2018-2023)
  • Table 82. Italy Epinephrine, by Type USD Million (2018-2023)
  • Table 83. Italy Epinephrine, by Application USD Million (2018-2023)
  • Table 84. Italy Epinephrine, by Route of Administration USD Million (2018-2023)
  • Table 85. Italy Epinephrine, by Ingredients USD Million (2018-2023)
  • Table 86. United Kingdom Epinephrine, by Type USD Million (2018-2023)
  • Table 87. United Kingdom Epinephrine, by Application USD Million (2018-2023)
  • Table 88. United Kingdom Epinephrine, by Route of Administration USD Million (2018-2023)
  • Table 89. United Kingdom Epinephrine, by Ingredients USD Million (2018-2023)
  • Table 90. Netherlands Epinephrine, by Type USD Million (2018-2023)
  • Table 91. Netherlands Epinephrine, by Application USD Million (2018-2023)
  • Table 92. Netherlands Epinephrine, by Route of Administration USD Million (2018-2023)
  • Table 93. Netherlands Epinephrine, by Ingredients USD Million (2018-2023)
  • Table 94. Rest of Europe Epinephrine, by Type USD Million (2018-2023)
  • Table 95. Rest of Europe Epinephrine, by Application USD Million (2018-2023)
  • Table 96. Rest of Europe Epinephrine, by Route of Administration USD Million (2018-2023)
  • Table 97. Rest of Europe Epinephrine, by Ingredients USD Million (2018-2023)
  • Table 98. MEA Epinephrine, by Country USD Million (2018-2023)
  • Table 99. MEA Epinephrine, by Type USD Million (2018-2023)
  • Table 100. MEA Epinephrine, by Application USD Million (2018-2023)
  • Table 101. MEA Epinephrine, by Route of Administration USD Million (2018-2023)
  • Table 102. MEA Epinephrine, by Ingredients USD Million (2018-2023)
  • Table 103. Middle East Epinephrine, by Type USD Million (2018-2023)
  • Table 104. Middle East Epinephrine, by Application USD Million (2018-2023)
  • Table 105. Middle East Epinephrine, by Route of Administration USD Million (2018-2023)
  • Table 106. Middle East Epinephrine, by Ingredients USD Million (2018-2023)
  • Table 107. Africa Epinephrine, by Type USD Million (2018-2023)
  • Table 108. Africa Epinephrine, by Application USD Million (2018-2023)
  • Table 109. Africa Epinephrine, by Route of Administration USD Million (2018-2023)
  • Table 110. Africa Epinephrine, by Ingredients USD Million (2018-2023)
  • Table 111. North America Epinephrine, by Country USD Million (2018-2023)
  • Table 112. North America Epinephrine, by Type USD Million (2018-2023)
  • Table 113. North America Epinephrine, by Application USD Million (2018-2023)
  • Table 114. North America Epinephrine, by Route of Administration USD Million (2018-2023)
  • Table 115. North America Epinephrine, by Ingredients USD Million (2018-2023)
  • Table 116. United States Epinephrine, by Type USD Million (2018-2023)
  • Table 117. United States Epinephrine, by Application USD Million (2018-2023)
  • Table 118. United States Epinephrine, by Route of Administration USD Million (2018-2023)
  • Table 119. United States Epinephrine, by Ingredients USD Million (2018-2023)
  • Table 120. Canada Epinephrine, by Type USD Million (2018-2023)
  • Table 121. Canada Epinephrine, by Application USD Million (2018-2023)
  • Table 122. Canada Epinephrine, by Route of Administration USD Million (2018-2023)
  • Table 123. Canada Epinephrine, by Ingredients USD Million (2018-2023)
  • Table 124. Mexico Epinephrine, by Type USD Million (2018-2023)
  • Table 125. Mexico Epinephrine, by Application USD Million (2018-2023)
  • Table 126. Mexico Epinephrine, by Route of Administration USD Million (2018-2023)
  • Table 127. Mexico Epinephrine, by Ingredients USD Million (2018-2023)
  • Table 128. Epinephrine: by Type(USD/Units)
  • Table 129. Company Basic Information, Sales Area and Its Competitors
  • Table 130. Company Basic Information, Sales Area and Its Competitors
  • Table 131. Company Basic Information, Sales Area and Its Competitors
  • Table 132. Company Basic Information, Sales Area and Its Competitors
  • Table 133. Company Basic Information, Sales Area and Its Competitors
  • Table 134. Company Basic Information, Sales Area and Its Competitors
  • Table 135. Company Basic Information, Sales Area and Its Competitors
  • Table 136. Company Basic Information, Sales Area and Its Competitors
  • Table 137. Company Basic Information, Sales Area and Its Competitors
  • Table 138. Company Basic Information, Sales Area and Its Competitors
  • Table 139. Epinephrine: by Type(USD Million)
  • Table 140. Epinephrine Epinephrine Auto-injector , by Region USD Million (2025-2030)
  • Table 141. Epinephrine Epinephrine Prefilled Syringe , by Region USD Million (2025-2030)
  • Table 142. Epinephrine Ampoules and Vials , by Region USD Million (2025-2030)
  • Table 143. Epinephrine Combination Epinephrine Products , by Region USD Million (2025-2030)
  • Table 144. Epinephrine: by Application(USD Million)
  • Table 145. Epinephrine Anaphylaxis , by Region USD Million (2025-2030)
  • Table 146. Epinephrine Cardiac Arrest , by Region USD Million (2025-2030)
  • Table 147. Epinephrine Others , by Region USD Million (2025-2030)
  • Table 148. Epinephrine: by Route of Administration(USD Million)
  • Table 149. Epinephrine Intravenous , by Region USD Million (2025-2030)
  • Table 150. Epinephrine Oral , by Region USD Million (2025-2030)
  • Table 151. Epinephrine Subcutaneous , by Region USD Million (2025-2030)
  • Table 152. Epinephrine Intramuscular , by Region USD Million (2025-2030)
  • Table 153. Epinephrine: by Ingredients(USD Million)
  • Table 154. Epinephrine Epinephrine Acetate , by Region USD Million (2025-2030)
  • Table 155. Epinephrine Epinephrine Bitartrate , by Region USD Million (2025-2030)
  • Table 156. Epinephrine Epinephrine Hydrochloride , by Region USD Million (2025-2030)
  • Table 157. South America Epinephrine, by Country USD Million (2025-2030)
  • Table 158. South America Epinephrine, by Type USD Million (2025-2030)
  • Table 159. South America Epinephrine, by Application USD Million (2025-2030)
  • Table 160. South America Epinephrine, by Route of Administration USD Million (2025-2030)
  • Table 161. South America Epinephrine, by Ingredients USD Million (2025-2030)
  • Table 162. Brazil Epinephrine, by Type USD Million (2025-2030)
  • Table 163. Brazil Epinephrine, by Application USD Million (2025-2030)
  • Table 164. Brazil Epinephrine, by Route of Administration USD Million (2025-2030)
  • Table 165. Brazil Epinephrine, by Ingredients USD Million (2025-2030)
  • Table 166. Argentina Epinephrine, by Type USD Million (2025-2030)
  • Table 167. Argentina Epinephrine, by Application USD Million (2025-2030)
  • Table 168. Argentina Epinephrine, by Route of Administration USD Million (2025-2030)
  • Table 169. Argentina Epinephrine, by Ingredients USD Million (2025-2030)
  • Table 170. Rest of South America Epinephrine, by Type USD Million (2025-2030)
  • Table 171. Rest of South America Epinephrine, by Application USD Million (2025-2030)
  • Table 172. Rest of South America Epinephrine, by Route of Administration USD Million (2025-2030)
  • Table 173. Rest of South America Epinephrine, by Ingredients USD Million (2025-2030)
  • Table 174. Asia Pacific Epinephrine, by Country USD Million (2025-2030)
  • Table 175. Asia Pacific Epinephrine, by Type USD Million (2025-2030)
  • Table 176. Asia Pacific Epinephrine, by Application USD Million (2025-2030)
  • Table 177. Asia Pacific Epinephrine, by Route of Administration USD Million (2025-2030)
  • Table 178. Asia Pacific Epinephrine, by Ingredients USD Million (2025-2030)
  • Table 179. China Epinephrine, by Type USD Million (2025-2030)
  • Table 180. China Epinephrine, by Application USD Million (2025-2030)
  • Table 181. China Epinephrine, by Route of Administration USD Million (2025-2030)
  • Table 182. China Epinephrine, by Ingredients USD Million (2025-2030)
  • Table 183. Japan Epinephrine, by Type USD Million (2025-2030)
  • Table 184. Japan Epinephrine, by Application USD Million (2025-2030)
  • Table 185. Japan Epinephrine, by Route of Administration USD Million (2025-2030)
  • Table 186. Japan Epinephrine, by Ingredients USD Million (2025-2030)
  • Table 187. India Epinephrine, by Type USD Million (2025-2030)
  • Table 188. India Epinephrine, by Application USD Million (2025-2030)
  • Table 189. India Epinephrine, by Route of Administration USD Million (2025-2030)
  • Table 190. India Epinephrine, by Ingredients USD Million (2025-2030)
  • Table 191. South Korea Epinephrine, by Type USD Million (2025-2030)
  • Table 192. South Korea Epinephrine, by Application USD Million (2025-2030)
  • Table 193. South Korea Epinephrine, by Route of Administration USD Million (2025-2030)
  • Table 194. South Korea Epinephrine, by Ingredients USD Million (2025-2030)
  • Table 195. Taiwan Epinephrine, by Type USD Million (2025-2030)
  • Table 196. Taiwan Epinephrine, by Application USD Million (2025-2030)
  • Table 197. Taiwan Epinephrine, by Route of Administration USD Million (2025-2030)
  • Table 198. Taiwan Epinephrine, by Ingredients USD Million (2025-2030)
  • Table 199. Australia Epinephrine, by Type USD Million (2025-2030)
  • Table 200. Australia Epinephrine, by Application USD Million (2025-2030)
  • Table 201. Australia Epinephrine, by Route of Administration USD Million (2025-2030)
  • Table 202. Australia Epinephrine, by Ingredients USD Million (2025-2030)
  • Table 203. Rest of Asia-Pacific Epinephrine, by Type USD Million (2025-2030)
  • Table 204. Rest of Asia-Pacific Epinephrine, by Application USD Million (2025-2030)
  • Table 205. Rest of Asia-Pacific Epinephrine, by Route of Administration USD Million (2025-2030)
  • Table 206. Rest of Asia-Pacific Epinephrine, by Ingredients USD Million (2025-2030)
  • Table 207. Europe Epinephrine, by Country USD Million (2025-2030)
  • Table 208. Europe Epinephrine, by Type USD Million (2025-2030)
  • Table 209. Europe Epinephrine, by Application USD Million (2025-2030)
  • Table 210. Europe Epinephrine, by Route of Administration USD Million (2025-2030)
  • Table 211. Europe Epinephrine, by Ingredients USD Million (2025-2030)
  • Table 212. Germany Epinephrine, by Type USD Million (2025-2030)
  • Table 213. Germany Epinephrine, by Application USD Million (2025-2030)
  • Table 214. Germany Epinephrine, by Route of Administration USD Million (2025-2030)
  • Table 215. Germany Epinephrine, by Ingredients USD Million (2025-2030)
  • Table 216. France Epinephrine, by Type USD Million (2025-2030)
  • Table 217. France Epinephrine, by Application USD Million (2025-2030)
  • Table 218. France Epinephrine, by Route of Administration USD Million (2025-2030)
  • Table 219. France Epinephrine, by Ingredients USD Million (2025-2030)
  • Table 220. Italy Epinephrine, by Type USD Million (2025-2030)
  • Table 221. Italy Epinephrine, by Application USD Million (2025-2030)
  • Table 222. Italy Epinephrine, by Route of Administration USD Million (2025-2030)
  • Table 223. Italy Epinephrine, by Ingredients USD Million (2025-2030)
  • Table 224. United Kingdom Epinephrine, by Type USD Million (2025-2030)
  • Table 225. United Kingdom Epinephrine, by Application USD Million (2025-2030)
  • Table 226. United Kingdom Epinephrine, by Route of Administration USD Million (2025-2030)
  • Table 227. United Kingdom Epinephrine, by Ingredients USD Million (2025-2030)
  • Table 228. Netherlands Epinephrine, by Type USD Million (2025-2030)
  • Table 229. Netherlands Epinephrine, by Application USD Million (2025-2030)
  • Table 230. Netherlands Epinephrine, by Route of Administration USD Million (2025-2030)
  • Table 231. Netherlands Epinephrine, by Ingredients USD Million (2025-2030)
  • Table 232. Rest of Europe Epinephrine, by Type USD Million (2025-2030)
  • Table 233. Rest of Europe Epinephrine, by Application USD Million (2025-2030)
  • Table 234. Rest of Europe Epinephrine, by Route of Administration USD Million (2025-2030)
  • Table 235. Rest of Europe Epinephrine, by Ingredients USD Million (2025-2030)
  • Table 236. MEA Epinephrine, by Country USD Million (2025-2030)
  • Table 237. MEA Epinephrine, by Type USD Million (2025-2030)
  • Table 238. MEA Epinephrine, by Application USD Million (2025-2030)
  • Table 239. MEA Epinephrine, by Route of Administration USD Million (2025-2030)
  • Table 240. MEA Epinephrine, by Ingredients USD Million (2025-2030)
  • Table 241. Middle East Epinephrine, by Type USD Million (2025-2030)
  • Table 242. Middle East Epinephrine, by Application USD Million (2025-2030)
  • Table 243. Middle East Epinephrine, by Route of Administration USD Million (2025-2030)
  • Table 244. Middle East Epinephrine, by Ingredients USD Million (2025-2030)
  • Table 245. Africa Epinephrine, by Type USD Million (2025-2030)
  • Table 246. Africa Epinephrine, by Application USD Million (2025-2030)
  • Table 247. Africa Epinephrine, by Route of Administration USD Million (2025-2030)
  • Table 248. Africa Epinephrine, by Ingredients USD Million (2025-2030)
  • Table 249. North America Epinephrine, by Country USD Million (2025-2030)
  • Table 250. North America Epinephrine, by Type USD Million (2025-2030)
  • Table 251. North America Epinephrine, by Application USD Million (2025-2030)
  • Table 252. North America Epinephrine, by Route of Administration USD Million (2025-2030)
  • Table 253. North America Epinephrine, by Ingredients USD Million (2025-2030)
  • Table 254. United States Epinephrine, by Type USD Million (2025-2030)
  • Table 255. United States Epinephrine, by Application USD Million (2025-2030)
  • Table 256. United States Epinephrine, by Route of Administration USD Million (2025-2030)
  • Table 257. United States Epinephrine, by Ingredients USD Million (2025-2030)
  • Table 258. Canada Epinephrine, by Type USD Million (2025-2030)
  • Table 259. Canada Epinephrine, by Application USD Million (2025-2030)
  • Table 260. Canada Epinephrine, by Route of Administration USD Million (2025-2030)
  • Table 261. Canada Epinephrine, by Ingredients USD Million (2025-2030)
  • Table 262. Mexico Epinephrine, by Type USD Million (2025-2030)
  • Table 263. Mexico Epinephrine, by Application USD Million (2025-2030)
  • Table 264. Mexico Epinephrine, by Route of Administration USD Million (2025-2030)
  • Table 265. Mexico Epinephrine, by Ingredients USD Million (2025-2030)
  • Table 266. Epinephrine: by Type(USD/Units)
  • Table 267. Research Programs/Design for This Report
  • Table 268. Key Data Information from Secondary Sources
  • Table 269. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Epinephrine: by Type USD Million (2018-2023)
  • Figure 5. Global Epinephrine: by Application USD Million (2018-2023)
  • Figure 6. Global Epinephrine: by Route of Administration USD Million (2018-2023)
  • Figure 7. Global Epinephrine: by Ingredients USD Million (2018-2023)
  • Figure 8. South America Epinephrine Share (%), by Country
  • Figure 9. Asia Pacific Epinephrine Share (%), by Country
  • Figure 10. Europe Epinephrine Share (%), by Country
  • Figure 11. MEA Epinephrine Share (%), by Country
  • Figure 12. North America Epinephrine Share (%), by Country
  • Figure 13. Global Epinephrine: by Type USD/Units (2018-2023)
  • Figure 14. Global Epinephrine share by Players 2023 (%)
  • Figure 15. Global Epinephrine share by Players (Top 3) 2023(%)
  • Figure 16. Global Epinephrine share by Players (Top 5) 2023(%)
  • Figure 17. BCG Matrix for key Companies
  • Figure 18. Mylan N.V.(United States) Revenue, Net Income and Gross profit
  • Figure 19. Mylan N.V.(United States) Revenue: by Geography 2023
  • Figure 20. Pfizer, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 21. Pfizer, Inc. (United States) Revenue: by Geography 2023
  • Figure 22. Teva Pharmaceuticals Industries Ltd. (Israel) Revenue, Net Income and Gross profit
  • Figure 23. Teva Pharmaceuticals Industries Ltd. (Israel) Revenue: by Geography 2023
  • Figure 24. Impax Laboratories, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 25. Impax Laboratories, Inc. (United States) Revenue: by Geography 2023
  • Figure 26. Kaleo, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 27. Kaleo, Inc. (United States) Revenue: by Geography 2023
  • Figure 28. Adamis Pharmaceuticals Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 29. Adamis Pharmaceuticals Corporation (United States) Revenue: by Geography 2023
  • Figure 30. Amphastar Pharmaceuticals (United States) Revenue, Net Income and Gross profit
  • Figure 31. Amphastar Pharmaceuticals (United States) Revenue: by Geography 2023
  • Figure 32. Merit Pharmaceutical (United States) Revenue, Net Income and Gross profit
  • Figure 33. Merit Pharmaceutical (United States) Revenue: by Geography 2023
  • Figure 34. Tianjin Jinyao Group (China) Revenue, Net Income and Gross profit
  • Figure 35. Tianjin Jinyao Group (China) Revenue: by Geography 2023
  • Figure 36. Bausch Health Companies (Canada) Revenue, Net Income and Gross profit
  • Figure 37. Bausch Health Companies (Canada) Revenue: by Geography 2023
  • Figure 38. Global Epinephrine: by Type USD Million (2025-2030)
  • Figure 39. Global Epinephrine: by Application USD Million (2025-2030)
  • Figure 40. Global Epinephrine: by Route of Administration USD Million (2025-2030)
  • Figure 41. Global Epinephrine: by Ingredients USD Million (2025-2030)
  • Figure 42. South America Epinephrine Share (%), by Country
  • Figure 43. Asia Pacific Epinephrine Share (%), by Country
  • Figure 44. Europe Epinephrine Share (%), by Country
  • Figure 45. MEA Epinephrine Share (%), by Country
  • Figure 46. North America Epinephrine Share (%), by Country
  • Figure 47. Global Epinephrine: by Type USD/Units (2025-2030)
List of companies from research coverage that are profiled in the study
  • Mylan N.V.(United States)
  • Pfizer, Inc. (United States)
  • Teva Pharmaceuticals Industries Ltd. (Israel)
  • Impax Laboratories, Inc. (United States)
  • Kaleo, Inc. (United States)
  • Adamis Pharmaceuticals Corporation (United States)
  • Amphastar Pharmaceuticals (United States)
  • Merit Pharmaceutical (United States)
  • Tianjin Jinyao Group (China)
  • Bausch Health Companies (Canada)
Additional players considered in the study are as follows:
ALK- Abello A/S (Denmark) , Sandoz (Germany) , INSYS Therapeutics,Inc. (United States)
Select User Access Type

Key Highlights of Report


Apr 2024 214 Pages 81 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Epinephrine Market Quantitative research analysis
Global Epinephrine Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as Mylan N.V.(United States), Pfizer, Inc. (United States), Teva Pharmaceuticals Industries Ltd. (Israel), Impax Laboratories, Inc. (United States), Kaleo, Inc. (United States), Adamis Pharmaceuticals Corporation (United States), Amphastar Pharmaceuticals (United States), Merit Pharmaceutical (United States), Tianjin Jinyao Group (China) and Bausch Health Companies (Canada) etc.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
"The Launch of New Products Like Epipen By Companies" is seen as one of major influencing trends for Epinephrine Market during projected period 2023-2030.
The Epinephrine market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete company list in our research coverage.

Know More About Global Epinephrine Market Report?

Have a Query? Click Here

Other Related Reports

Healthcare Outsourcing Comprehensive Study by Type (Payer Outsourcing, Healthcare Operations Outsourcing, Healthcare Provider, Pharma Outsourcing, Pathology and Lab Outsourcing), Technology (Monoclon...
$ 3750
ePharmacy Comprehensive Study by Type (Skin Care, Dental, Cold and Flu, Vitamins, Weight Loss, Other), Drug Type (Prescription Drugs, Over-The-Counter (OTC) Drugs), Mode of Use (Mobile Applications, ...
$ 3350
Hybrid OR Comprehensive Study by Type (Operating Tables, Operating Room Lights, Surgical Imaging Displays, Intraoperative Diagnostic Devices, Operating Room Communication Systems), Application (Clini...
$ 3350
Jet Lag Therapy Comprehensive Study by Application (Business Travelers, Cabin Crew, Athletes, Seasonal Travelers, Others), End Users (Hospital Pharmacies, Retail Pharmacies, Online Sales, Drug Stores...
$ 3750
Atrial Fibrillation Surgery Comprehensive Study by Type (Ablation Surgeries (Radiofrequency Ablation, Sonar, Microwave, Cryoablation), Atrioventricular Node Ablation, Maze Procedure), Application (Mi...
$ 3650
Electric Oral Care Comprehensive Study by Type (Water Flosser/Oral Irrigators, Air Flosser), Application (Online Stores, Retail Stores), End users (Adults, Children, Geriatric Population), Distributi...
$ 3350